Treatment of giant keratoacanthoma of the skin of the lower lip with intralesional methotrexate: A case report

Journal of Oral and Maxillofacial Surgery

Volumn 60, Issue 1, 2002, Pages 93-95

  De Visscher, Jan G A M ^a   Van der Wal, Karel G H ^a   Blanken, Rob ^b   Willemse, Feike ^c  

^a Department of Oral and Maxillofacial Surgery ^*  (Netherlands)

^b Medisch Centrum   (Netherlands)

^c Public Health Service of Northern Friesland   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; BISMUTH; BLEOMYCIN; FLUOROURACIL; METHOTREXATE; PODOPHYLLIN; TRIAMCINOLONE;

AGED; ARGON LASER; ARTICLE; BIOPSY; CASE REPORT; CHEMOSURGERY; CLINICAL FEATURE; CRYOSURGERY; CURETTAGE; DIFFERENTIAL DIAGNOSIS; EXCISION; HISTOLOGY; HUMAN; HUMAN TISSUE; KERATOACANTHOMA; LOWER LIP; MALE; MALIGNANT TRANSFORMATION; SCAR; SEX DIFFERENCE; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

EID: 0036142548     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1053/joms.2002.29083     Document Type: Article

References (10)

1. Keratoacanthoma
2. The etiology of keratoacanthoma
3. Massive or giant keratoacanthoma
4. Nucleolar organizer region enumeration in keratoacanthomas and squamous cell carcinomas of the skin
5. Proliferating cell nuclear antigen distribution in keratoacanthoma and squamous cell carcinoma
6. p53 oncoprotein expression and proliferation index in keratoacanthoma and squamous cell carcinoma
7. The regressing keratoacanthoma
8. Solitary keratoacanthoma is a squamous-cell carcinoma: Three examples with metastases
9. Solitary keratoacanthoma (squamous cell carcinoma): Surgical management
10. Treatment of keratoacanthoma with intralesional methotrexate